Clinical trials
Autoimmune Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 26 |
| 2025 | 29 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 48 |
| Unknown status | 23 |
| Completed | 17 |
| Not yet recruiting | 13 |
| Withdrawn | 8 |
| Active, not recruiting | 6 |
| Terminated | 3 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 10 |
| Zhejiang University | 7 |
| The Children's Hospital of Zhejiang University School of Medicine | 6 |
| Beijing Boren Hospital | 5 |
| Anhui Provincial Hospital | 3 |
| Changhai Hospital | 3 |
| Essen Biotech | 3 |
| Nanjing Legend Biotech Co. | 3 |
| Novartis Pharmaceuticals | 3 |
| RemeGen Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 120 |
| Lupus Erythematosus, Systemic | 32 |
| Scleroderma, Systemic | 17 |
| Immune System Diseases | 16 |
| Myositis | 11 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 10 |
| Recurrence | 10 |
| Sjogren's Syndrome | 10 |
| Connective Tissue Diseases | 8 |
| Arthritis, Rheumatoid | 7 |
Trials
Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.